BIOAVAILABILITY OF PHENYTOIN

被引：10

作者：

GUGLER, R

FROSCHER, W

EICHELBAUM, M

HILDENBRAND, G

机构：

[1] UNIV BONN,MED KLIN,D-5300 BONN 1,FED REP GER

[2] UNIV BONN,NERVEN KLIN,D-5300 BONN 1,FED REP GER

[3] UNIV BONN,INST MED STAT,DOKUMENTAT & DATENVERARBEITUNG,D-5300 BONN 1,FED REP GER

来源：

JOURNAL OF NEUROLOGY | 1977年 / 216卷 / 03期

关键词：

D O I：

10.1007/BF00313616

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：155 / 162

页数：8

共 27 条

[1]

ALBERT KS, 1974, CLIN PHARMACOL THER, V16, P727

[2]

ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121

[3]

ARNOLD K, 1970, CAN J PHARM SCI, V5, P89

[4] IDENTIFICATION OF 5-META-HYDROXYPHENYL-5-PHENYLHYDANTOIN AS A METABOLITE OF DIPHENYLHYDANTOIN [J].

ATKINSON, AJ ;

MACGEE, J ;

STRONG, J ;

GARTEIZ, D ;

GAFFNEY, TE .

BIOCHEMICAL PHARMACOLOGY, 1970, 19 (08) :2483-&

[5] MICROMETHOD FOR DETERMINATION OF DIPHENYLHYDANTOIN IN PLASMA AND CEREBROSPINAL-FLUID - COMPARISON BETWEEN A GAS-CHROMATOGRAPHIC AND A SPECTROPHOTOMETRIC METHOD [J].

BERLIN, A ;

BORGA, O ;

AGURELL, S ;

SJOQVIST, F ;

LUND, L .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 (03) :281-&

[6]

DILL WA, 1956, J PHARMACOL EXP THER, V118, P270

[7]

Eadie M J, 1968, Med J Aust, V2, P515

[8] The use of ranks to avoid the assumption of normality implicit in the analysis of variance [J].

Friedman, M .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1937, 32 (200) :675-701

[9]

GERBER N, 1972, RES COMMUN CHEM PATH, V3, P455

[10]

GLAZKO AJ, 1972, PHARMACOLOGY, V8, P163

← 1 2 3 →